• Save
Global Biotechnology Market is expected to reach USD 414.5 billion in 2017 : Transparency Market Research
Upcoming SlideShare
Loading in...5
×

Like this? Share it with your network

Share

Global Biotechnology Market is expected to reach USD 414.5 billion in 2017 : Transparency Market Research

  • 501 views
Uploaded on

According to a new market report published by Transparency Market Research, "Biotechnology Market by Application (Biopharmacy, Bioservices, Bioagri, Bioindustrial), by Technology (Fermentation,......

According to a new market report published by Transparency Market Research, "Biotechnology Market by Application (Biopharmacy, Bioservices, Bioagri, Bioindustrial), by Technology (Fermentation, Tissue Regeneration, PCR, Nanobiotechnology, DNA Sequencing & Others) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2010 - 2017," the global market for biotechnology was valued at USD 216.5 billion in 2011 and is expected to reach USD 414.5 billion in 2017, growing at a CAGR of 11.6% from 2012 to 2017.

Browse the full report at http://www.transparencymarketresearch.com/biotechnology-market.html

More in: Technology , Business
  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Be the first to comment
    Be the first to like this
No Downloads

Views

Total Views
501
On Slideshare
501
From Embeds
0
Number of Embeds
0

Actions

Shares
Downloads
0
Comments
0
Likes
0

Embeds 0

No embeds

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
    No notes for slide

Transcript

  • 1. REPORT DESCRIPTIONGlobal Biotechnology Market - Global Industry Analysis, Size, Share, Growth,Trends And Forecast, 2010 – 2017The biotechnology market is expected to show substantial growth over the forecast periodowing to regulatory support offered to various companies operating in the biotechnologyfield. In addition, the increased demand for food in developing countries has spurred thegrowth of the bioagriculture market. Bioseeds are expected to show exponential growth ascompared to conventional seeds over the forecast period.This report on the biotechnology market analyzes and estimates the global revenuegenerated by the biotechnology industry over the forecast period i.e. 2012 to 2017. Thescope of the report considers biotechnology to be divided into four primary segmentsnamely biopharmacy, bioservices, bioagriculture and bioindustrial. In terms of technology,the biotechnology market has been segmented into fermentation, tissue regeneration, PCRtechnology, nanobiotechnology, chromatography, DNA sequencing, cell based assay andTransparency Market ResearchGlobal BiotechnologyMarket - Global IndustryAnalysis, Size, Share,Growth, Trends AndForecast, 2010 – 2017Single User License: US $ 4595Multi User License: US $ 7595Corporate User License: US $ 10795Buy NowRequest SamplePublished Date: APR 2013115 Pages Report
  • 2. Browse Report : Global Biotechnology Marketothers. The others segment comprises of genetic engineering, enzyme technology andfingerprinting among others.Biopharmacy comprises of various pharmaceuticals manufactured by using biotechnologyand also covers medical devices. The bioservices segment predominantly comprises of CROs(Contract Research Organizations) which are third party organizations performing clinicaltrials, drug discovery and contract manufacturing. The bioindustrial application includes theuse of bioenzymes and biochemicals for a variety of chemical processes. Bioagriculturecomprises of bioseeds and genetically modified (GM) crops.The study explains the various drivers and restraints affecting the market along with theimpact they would have over the forecast period. A detailed analysis of the opportunitiesavailable in the market over the next five years has also been included. The value chain forthe biotechnology market has been provided for a better understanding of the processfollowed in the market. The study covers in detail the Porters Five Forces analysis, whichgives the users of this report a better perspective into the present and future marketscenarios. The market has been segmented based on technology, application andgeography. Apart from the global application overview, the report further segregates theapplications for regions such as North America, Europe, Asia Pacific and Rest of the World(RoW).Key market players in the report include Roche, Amgen, Novo Nordisk, Sanofi and Pfizeramong others. A detailed company market share has been included to give a betterunderstanding of the competitive situation in the market. In addition, these companies havebeen profiled with respect to attributes such as company overview, financial overview,SWOT analysis, business strategy and recent developments.Biotechnology Market, by Technology: Fermentation Tissue regeneration PCR technology Nanobiotechnology Chromatography DNA sequencing Cell based assay Others
  • 3. Biotechnology Market, by Application: Biopharmacy Bioservices Bioagriculture BioindustrialThe report provides a cross-sectional analysis of all the above applications withrespect to the following geographical markets: North America Europe Asia Pacific Rest of the World (RoW)The detailed analysis and research will help biotechnology companies, retailers and R&Dinstitutes to make well-informed decisions about manufacturing, marketing and sales and inturn help them gain competitive advantage.TABLE OF CONTENTSChapter 1 Preface1.1 Report Description1.2 Research MethodologyChapter 2 Executive SummaryChapter 3 Market Overview3.1 Introduction3.2 Value Chain Analysis3.3 Market Drivers3.3.1 Regulatory Support3.3.2 Increasing Food Demand
  • 4. Browse Report : http://www.transparencymarketresearch.com/biotechnology-market.html3.3.3 Limited Availability of Non-Renewable Natural Resources3.4 Market Restraints3.4.1 Ethical Issues Associated with Clinical Trials3.4.2 Long Research and Development Lead Time3.5 Market Opportunities3.5.1 Emergence of Biosimilars3.5.2 Biotechnology in Medical Sciences3.6 Porters Five Force Analysis3.6.1 Bargaining Power of Suppliers3.6.2 Bargaining Power of Buyers3.6.3 Threat of New Entrants3.6.4 Threat from Substitutes3.6.5 Degree of Competition3.7 Biotechnology: Company Market Share Analysis3.8 Biotechnology: Market Attractiveness Analysis3.8.1 Biotechnology Market, by Application: Attractiveness Analysis3.8.2 Biotechnology Market, by Technology: Attractiveness AnalysisChapter 4 Global Biotechnology Market, by Application4.1 Global Biotechnology Market: Application Overview4.1.1 Global Biotechnology Market Revenue Share, by Application, 2010 and 20174.2 Biotechnology Market, by Application, 2010 - 20174.2.1 Biopharmacy4.2.1.1 Global Biopharmacy Market, 2010 – 2017 (USD Billion)4.2.2 Bioservices4.2.2.1 Global Bioservices Market, 2011 – 2017 (USD Billion)
  • 5. 4.2.3 Bioagriculture4.2.3.1 Global Bioagriculture Market, 2010 – 2017 (USD Billion)4.2.4 Bioindustrial4.2.4.1 Global Bioindustrial Market, 2011 – 2017 (USD Billion)Chapter 5 Global Biotechnology Market, by Technology5.1 Global Biotechnology Market Overview, by Technology5.1.1 Global Biotechnology Market Revenue Share, by Technology, 2010 And 20175.2 Fermentation Technology5.2.1 Global Fermentation Technology Market, 2010 – 2017 (USD Billion)5.3 Tissue Engineering And Regeneration Technology5.3.1 Global Tissue Engineering and Regeneration Technology Market, 2010 – 2017(USD Billion)5.4 Polymerase Chain Reaction (PCR) Technology5.4.1 Global PCR Technology Market, 2010 – 2017 (USD Billion)5.5 Nanobiotechnology5.5.1 Global Nanobiotechnology Market, 2010 – 2017 (USDBillion)5.6 Chromatography5.6.1 Global Chromatography Market, 2010 – 2017 (USD Billion)5.7 Dna Sequencing Technology5.7.1 Global DNA Sequencing Technology Market, 2010 – 2017 (USD Billion)5.8 Cell Based Assay5.8.1 Global Cell Based Assay Market, 2010 – 2017 (USD Billion)5.9 Others (Enzyme Technology, Finger Printing, Etc.)5.9.1 Global Other Technologies Market, 2010 – 2017 (USD Billion)Chapter 6 Global Biotechnology Market, by Geography6.1 Global Biotechnology Market Overview, by Geography
  • 6. Browse Report : http://www.transparencymarketresearch.com/biotechnology-market.html6.1.1 Global Biotechnology Market Revenue Share,by Geography, 2011 and 20176.2 North America6.2.1 North America Market for Biotechnology, 2010 – 2017, (USD Billion)6.2.2 North America Market Demand For Biotechnology, By Application, 2010 – 2017,(USD Billion)6.2.2.1 Demand for Biopharmacy in North America, 2010 – 2017, (USD Billion)6.2.2.2 Demand for Bioservices in North America, 2010 – 2017, (USD Billion)6.2.2.3 Demand for Bioagriculture in North America, 2010 – 2017, (USD Billion)6.2.2.4 Demand for Bioindustrial Products in North America, 2010 – 2017, (USDBillion)6.3 Europe6.3.1 Europe Market for Biotechnology, 2010 – 2017, (USD Billion)6.3.2 Europe Market Demandfor Biotechnology, by Application, 2010 – 2017, (USDBillion)6.3.2.1 Demandfor Biopharmacyin Europe, 2010 – 2017, (USD Billion)6.3.2.2 Demand for Bioservices in Europe, 2010 – 2017, (USD Billion)6.3.2.3 Demand for Bioagriculture in Europe, 2010 – 2017, (USD Billion)6.3.2.4 Demand for Bioindustrial Products in Europe, 2010 – 2017, (USD Billion)6.4 Asia Pacific6.4.1 Asia Pacific Market for Biotechnology, 2010 – 2017, (USD Billion)6.4.2 Asia Pacific Market Demandfor Biotechnology, by Application, 2010 – 2017, (USDBillion)6.4.2.1 Demand for Biopharmacy in Asia Pacific, 2010 – 2017, (USD Billion)6.4.2.2 Demand For Bioservices in Asia Pacific, 2010 – 2017, (USD Billion)6.4.2.3 Demand For Bioagriculture in Asia Pacific, 2010 – 2017, (USD Billion)6.4.2.4 Demand For Bioindustrial Products in Asia Pacific, 2010 – 2017, (USDBillion)6.5 Rest Of World
  • 7. 6.5.1 Rest of World Market for Biotechnology, 2010 – 2017, (USD Billion)6.5.2 Rest Of World (Row) Market Demand for Biotechnology, by Application, 2010 –2017, (USD Billion)6.5.2.1 Demandfor Biopharmacy in Row, 2010 – 2017, (USDBillion)6.5.2.2 Demand for Bioservices in Row, 2010 – 2017, (USD Billion)6.5.2.3 Demand for Bioagriculture in Row, 2010 – 2017, (USD Billion)6.5.2.4 Demand for Bioindustrial Products in Row, 2010 – 2017, (USD Billion)Chapter 7 Company Profile7.1 Abbott Laboratories7.1.1 Company Overview7.1.2 Financial Overview7.1.3 Business Strategies7.1.4 Swot Analysis7.1.5 Recent Developments7.2 Amgen Inc.7.2.1 Company Overview7.2.2 Financial Overview7.2.3 Business Strategy7.2.4 Swot Analysis7.2.5 Recent Developments7.3 Glaxosmithkline7.3.1 Company Overview7.3.2 Financial Overview7.3.3 Business Strategy7.3.4 Swot Analysis
  • 8. Browse Report : http://www.transparencymarketresearch.com/biotechnology-market.html7.3.5 Recent Developments7.4 Johnson And Johnson7.4.1 Company Overview7.4.2 Financial Overview7.4.3 Business Strategy.7.4.4 Swot Analysis7.4.5 Recent Developments7.5 Merck7.5.1 Company Overview7.5.2 Financial Overview7.5.3 Business Strategy7.5.4 Swot Analysis7.5.5 Recent Developments7.6 Novartis7.6.1 Company Overview7.6.2 Financial Overview7.6.3 Business Strategy7.6.4 Swot Analysis7.6.5 Recent Developments7.7 Novo Nordisk7.7.1 Company Overview7.7.2 Financial Overview7.7.3 Swot Analysis7.7.4 Business Strategies7.7.5 Recent Developments
  • 9. 7.8 Pfizer (Wyeth)7.8.1 Company Overview7.8.2 Financial Overview7.8.3 Business Strategies.7.8.4 Swot Analysis7.8.5 Recent Developments7.9 Roche7.9.1 Company Overview7.9.2 Financial Overview7.9.3 Business Strategies7.9.4 Swot Analysis7.9.5 Recent Developments7.10 Sanofi - Aventis7.10.1 Company Overview7.10.2 Financial Overview7.10.3 Business Strategy7.10.4 Swot Analysis7.10.5 Recent Developments7.11 Lonza Group Ltd.7.11.1 Company Overview7.11.2 Financial Overview7.11.3 Business Strategy7.11.4 Swot Analysis7.11.5 Recent Developments7.12 Biogen Idec Inc7.12.1 Company Overview
  • 10. Browse Report : http://www.transparencymarketresearch.com/biotechnology-market.html7.12.2 Financial Overview7.12.3 Business Strategy7.12.4 Swot Analysis7.12.5 Recent Developments7.13 Astra Zeneca7.13.1 Company Overview7.13.2 Financial Overview7.13.3 Business Strategy7.13.4 Swot Analysis7.13.5 Recent Developments7.14 Genentech7.14.1 Company Overview7.14.2 Financial Overview7.14.3 Business Strategies7.14.4 Swot Analysis7.14.5 Recent Developments7.15 Genzyme7.15.1 Company Overview7.15.2 Financial Overview7.15.3 Swot Analysis7.15.4 Recent Developments7.16 Gilead Sciences7.16.1 Company Overview7.16.2 Financial Overview7.16.3 Swot Analysis
  • 11. 7.16.4 Business Strategies7.16.5 Recent Developments7.17 Celgene7.17.1 Company Overview7.17.2 Financial Overview7.17.3 Business Strategy7.17.4 Swot Analysis7.17.5 Recent DevelopmentsAbout Us:Transparency Market Research is a market intelligence company providing global businessinformation reports and services. Our exclusive blend of quantitative forecasting and trendsanalysis provides forward-looking insight for thousands of decision makers.We are privileged with highly experienced team of Analysts, Researchers and Consultants,who use proprietary data sources and various tools and techniques to gather, and analyzeinformation. Our business offerings represent the latest and the most reliable informationindispensable for businesses to sustain a competitive edge.Contact:Transparency Market Research90 State Street,Suite 700,AlbanyNY - 12207United StatesTel: +1-518-618-1030USA - Canada Toll Free 866-552-3453Email: sales@transparencymarketresearch.comWebsite: http://www.transparencymarketresearch.com/